SWTX:NSD-SpringWorks Therapeutics Inc (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 32.83

Change

+0.61 (+1.89)%

Market Cap

N/A

Volume

1.12M

Analyst Target

USD 54.40
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
VRTX Vertex Pharmaceuticals Inc

-7.62 (-1.62%)

USD 119.56B
REGN Regeneron Pharmaceuticals Inc

-6.64 (-0.63%)

USD 114.65B
ALNY Alnylam Pharmaceuticals Inc

-4.51 (-1.63%)

USD 35.44B
ARGX argenx NV ADR

+2.72 (+0.50%)

USD 32.73B
MRNA Moderna Inc

-0.77 (-1.20%)

USD 25.27B
BGNE BeiGene Ltd

+2.62 (+1.13%)

USD 24.38B
RPRX Royalty Pharma Plc

-0.14 (-0.49%)

USD 16.72B
UTHR United Therapeutics Corporatio..

-5.36 (-1.50%)

USD 15.95B
SMMT Summit Therapeutics PLC

-0.56 (-2.79%)

USD 15.35B
PCVX Vaxcyte Inc

-1.29 (-1.12%)

USD 14.00B

ETFs Containing SWTX

BANK:CA Evolve Canadian Banks and.. 12.81 % 0.39 %

+0.02 (+0.17%)

CAD 0.25B
HFIN:CA Hamilton Enhanced Canadia.. 10.32 % 0.00 %

+0.03 (+0.17%)

CAD 0.16B
CEW:CA iShares Equal Weight Banc.. 9.88 % 0.60 %

N/A

CAD 0.22B
FLI:CA CI U.S. & Canada Lifeco C.. 9.21 % 0.92 %

+0.03 (+0.17%)

CAD 0.09B
HEF:CA 7.65 % 0.83 %

N/A

N/A
TQCD:CA TD Q Canadian Dividend ET.. 3.61 % 0.00 %

-0.06 (0.17%)

CAD 0.38B
CDEF:CA Manulife Smart Defensive .. 2.54 % 0.00 %

N/A

CAD 1.39M
HPR:CA Global X Active Preferred.. 1.89 % 0.63 %

+0.06 (+0.17%)

CAD 1.05B
DXM:CA 0.00 % 0.67 %

N/A

N/A
PR:CA Lysander-Slater Preferred.. 0.00 % 1.03 %

-0.01 (0.17%)

CAD 0.08B
RODM Hartford Multifactor Deve.. 0.00 % 0.31 %

-0.10 (0.17%)

N/A
XMD:CA iShares S&P/TSX Completio.. 0.00 % 0.61 %

+0.06 (+0.17%)

CAD 0.22B
BNC:CA 0.00 % 0.68 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -10.05% 56% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -10.05% 56% F 38% F
Trailing 12 Months  
Capital Gain 42.00% 72% C 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 42.00% 72% C 80% B-
Trailing 5 Years  
Capital Gain 80.88% 79% B- 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 80.88% 79% B- 78% C+
Average Annual (5 Year Horizon)  
Capital Gain 26.87% N/A N/A 82% B
Dividend Return 26.87% N/A N/A 82% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 77.05% N/A N/A 23% F
Risk Adjusted Return 34.87% N/A N/A 67% D+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector